Revance Therapeutics, Inc.: S-8 POS filed Feb 12, 2025

Form type

S-8 POS

Filing date

Feb 12, 2025

Accession number

0001193125-25-024792

Filer

Revance Therapeutics, Inc. (CIK 1479290)